Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-20 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Sale 10b5-1 −801 $420.79 $337K 19,710
2024-02-20 Arbuckle Stuart A EVP, COO Shares withheld for taxes 10b5-1 −3,373 $420.58 $1.4M 67,846
2024-02-20 Arbuckle Stuart A EVP, COO Sale 10b5-1 −4,804 $420.79 $2.0M 63,042
2024-02-20 ALTSHULER DAVID EVP, Global Research and CSO Shares withheld for taxes 10b5-1 −2,812 $420.58 $1.2M 41,026
2024-02-20 ALTSHULER DAVID EVP, Global Research and CSO Sale 10b5-1 −4,002 $420.79 $1.7M 37,024
2024-02-16 WAGNER CHARLES F JR EVP & Chief Financial Officer Shares withheld for taxes −3,750 $424.01 $1.6M 59,704
2024-02-16 Tatsis Ourania EVP, Chief Reg. & Quality Off. Shares withheld for taxes 10b5-1 −4,499 $424.01 $1.9M 63,680
2024-02-16 Sachdev Amit EVP Chief Patient & Ext Af Off Shares withheld for taxes 10b5-1 −3,498 $424.01 $1.5M 70,866
2024-02-16 Kewalramani Reshma CEO & President Shares withheld for taxes −9,359 $424.01 $4.0M 152,912
2024-02-16 Bozic Carmen EVP and CMO Shares withheld for taxes −3,750 $424.01 $1.6M 43,060
2024-02-16 Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. Shares withheld for taxes 10b5-1 −1,501 $424.01 $636K 21,636
2024-02-16 Arbuckle Stuart A EVP, COO Shares withheld for taxes 10b5-1 −4,499 $424.01 $1.9M 71,219
2024-02-16 ALTSHULER DAVID EVP, Global Research and CSO Shares withheld for taxes 10b5-1 −3,750 $424.01 $1.6M 43,838
2024-02-15 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −4,655 $419.16 $2.0M 17,896
2024-02-14 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −4,356 $419.04 $1.8M 22,551
2024-02-13 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −737 $419.13 $309K 26,907
2024-02-12 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −2,009 $419.22 $842K 28,291
2024-02-12 LEIDEN JEFFREY M Executive Chairman Sale 10b5-1 −647 $420.39 $272K 27,644
2024-02-12 Tatsis Ourania EVP, Chief Reg. & Quality Off. Sale 10b5-1 −314 $420.24 $132K 68,179
2024-02-12 Sachdev Amit EVP Chief Patient & Ext Af Off Sale 10b5-1 −3,222 $420.24 $1.4M 74,364

Page 23 of 27 · 524 trades